Funding cuts have shaken every state, but the South is acutely vulnerable when it comes to HIV, said Gregorio Millett, MPH, ...

Scientists have identified a promising new class of treatments for Alzheimer's disease, and they're already widely used to ...

As the Trump administration slashes funding for HIV-related research and infrastructure, Gilead, Immunocore and more are ...

ABC News' Dr. Tara Narula breaks down a new study suggesting that a common HIV medication may significantly reduce the risk ...

In the face of a fear of loss of funds for ending the HIV/AIDS epidemic, activists in New Jersey walked to raise money.

On April 22, the CDC allegedly informed Emory University in Atlanta that its large HIV self-testing program was being ...

Even after decades of research, there is no cure for the disease HIV causes, AIDS. But lenacapavir, born out of research on ...

A panelist discusses how a new drug combination of doravirine and islatravir was compared to a standard bictegravir-based ...

A free and confidential online HIV testing service will be expanded with new funding to support measures to eliminate new ...

Researchers at UVA Health are urging for clinical trials to explore whether certain HIV medications, known as nucleoside ...

UVA scientists are calling for clinical trials to see if common HIV drugs could prevent up to 1 million new Alzheimer’s cases ...

A panelist discusses how the new doravirine and islatravir combination offers an alternative to integrase inhibitor-based ...